Literature DB >> 27716760

Ex vivo and simulator models teaching therapeutic ERCP and EUS: description of SOBED's first course.

Everson L A Artifon1, Mauro E Ramirez1, José C Ardengh1, Maria Cristina Sartor1, Gabriel M Favaro1, Emilio Belmonte1, Julio Lobo1, Djalma Coelho1, Julio Pereira-Lima1, Cesar V Lopez1, Sergio E Matuguma1, Carlos K Furuya1, Julio Pisani1, Spencer Cheng1, Marco A Buch1, Tomazo Franzini1, Tiago F Vilela1, Ricardo Pessoa1, Eduardo Bonin1, Marcos Lera1, Thaisa S Nakadomari1, Leandro Y Kashiwagui1, Marlus T Gerber1, Ramiro Mascarenhas1.   

Abstract

Teaching models in endoscopy are important tools to minimize risks derived from endoscopic procedures, taking into account that therapeutic endoscopy, also known as surgical endoscopy, has greatly developed during the last decade. This results from the fact that minimally invasive procedures present relevant contributions and promote more comfort to patients. In this context, ex vivo teaching models and virtual simulators are important tools to the safe acquisition of abilities. In this article, the Brazilian Society of Digestive Endoscopy presents and describes its first course of therapeutic ERCP and EUS in models of laboratory teaching.

Entities:  

Mesh:

Year:  2016        PMID: 27716760

Source DB:  PubMed          Journal:  Rev Gastroenterol Peru        ISSN: 1022-5129


  2 in total

1.  AN INNOVATIVE EX-VIVO MODEL FOR RAPID CHANGE OF THE PAPILLA FOR TEACHING ADVANCED ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY PROCEDURES.

Authors:  Everson L A Artifon; Thaisa S Nakadomari; Leandro Y Kashiwagui; Emilio A Belmonte; Cláudio R Solak; Spencer Cheng; Carlos K Furuya; Jose P Otoch
Journal:  Arq Bras Cir Dig       Date:  2016 Nov-Dec

2.  Escalating complexity of endoscopic retrograde cholangiopancreatography over the last decade with increasing reliance on advanced cannulation techniques.

Authors:  Monique T Barakat; Mohit Girotra; Nirav Thosani; Shivangi Kothari; Subhas Banerjee
Journal:  World J Gastroenterol       Date:  2020-11-07       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.